8-K Announcements
6Material company update
Jun 15, 2026·SEC
Material company update
Apr 22, 2026·SEC
Material company update
Apr 21, 2026·SEC
Bullfrog AI Holdings, Inc. Warrants(BFRGW)Earnings, Financials & Key Ratios
BFRGW•NASDAQ
$0.12
Price updated Jun 27, 2026
AboutBullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.Show more
- Revenue$117K
- EBITDA-$7M+8.9%
- Net Income-$6M+7.1%
- EPS (Diluted)-0.63+25.9%
- Gross Margin17.29%
- EBITDA Margin-5650.91%
- Operating Margin-5652.38%
- Net Margin-5569.61%
- ROE-183.04%+1.1%
BFRGW Price & Volume
Bullfrog AI Holdings, Inc. Warrants (BFRGW) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operating Losses Threaten Liquidity Runway Stability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and insolvency risk
"Bullfrog AI Holdings faces a precarious financial outlook characterized by negligible commercial traction and a reliance on intermittent pilot-based consulting engagements. The firm's inability to scale revenue beyond a TTM total of $116,670, coupled with consistent quarterly operating losses exceeding $1.3 million, suggests significant insolvency risk. Investors should monitor the company's ability to secure non-dilutive capital or achieve clinical milestones, as the current cash burn rate threatens to exhaust the $5.1 million cash position without immediate strategic intervention."
Verdict Logic
the company's precarious financial position is highlighted by a persistent quarterly cash burn that threatens its $5.1 million cash balance, leaving little room for error in its speculative drug discovery model.
BFRGW Growth Metrics
Bullfrog AI Holdings, Inc. Warrants (BFRGW) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years126.81%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM14.54%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM34.52%
Return on Capital
10 Years-194.79%
5 Years-194.79%
3 Years-194.79%
Last Year-185.76%
Peers Comparison
Key metrics vs top competitors for Bullfrog AI Holdings, Inc. Warrants (BFRGW)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.12 | $1.57M | -0.20 | — | -5569.61% | -183.04% | — | |
| $0.65 | $8.48M | -1.04 | — | -5205.86% | -217.79% | — | |
| $3.52 | $1.57B | -2.44 | 26.92% | -844.46% | -54.32% | — | |
| $10.89 | $1.7B | -12.96 | -38.24% | -6450.76% | -63.58% | — | |
| $1.99 | $1.05M | -0.01 | -82.47% | -140.37% | — | — | |
| $16.86 | $1.26B | -11.96 | 23.29% | -40.6% | -30.85% | — |
Compare BFRGW vs Peers
Bullfrog AI Holdings, Inc. Warrants (BFRGW) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BFRGW SEC Filings & Documents
Bullfrog AI Holdings, Inc. Warrants (BFRGW) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when BFRGW posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BFRGW Frequently Asked Questions
Bullfrog AI Holdings, Inc. Warrants (BFRGW) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Bullfrog AI Holdings, Inc. Warrants's revenue?
Bullfrog AI Holdings, Inc. Warrants (BFRGW) reported $0.1M in revenue for fiscal year 2025.
Is BFRGW profitable?
Bullfrog AI Holdings, Inc. Warrants (BFRGW) reported a net loss of $6.1M for fiscal year 2025.
Dividend & Returns
What is BFRGW's return on equity?
Bullfrog AI Holdings, Inc. Warrants (BFRGW) has a return on equity (ROE) of -183.0%. Negative ROE indicates the company is unprofitable.
What is Bullfrog AI Holdings, Inc. Warrants's free cash flow?
Bullfrog AI Holdings, Inc. Warrants (BFRGW) had negative free cash flow of $5.4M in fiscal year 2025, likely due to heavy capital investments.